Stockreport

FDA halts new patient recruitment in Aduro's LADD clinical programs due to possible Listeria infection; shares off 11% premarket [Seeking Alpha]

ADURO BIOTECH  (ADRO) 
Last aduro biotech earnings: 3/9 04:15 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.aduro.com
PDF Aduro Biotech (NASDAQ: ADRO ) eases   premarket on increased volume in response to its announcement that the FDA has placed a partial clinical hold on its LADD ( [Read more]